Ocimum Labs Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 07-07-2024
- Paid Up Capital ₹ 14.16 Cr
as on 07-07-2024
- Company Age 6 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 61.79 Cr
as on 07-07-2024
- Satisfied Charges ₹ 21.50 Cr
as on 07-07-2024
- Revenue 134.14%
(FY 2023)
- Profit -22.67%
(FY 2023)
- Ebitda 91.00%
(FY 2023)
- Net Worth 23.67%
(FY 2023)
- Total Assets 51.44%
(FY 2023)
About Ocimum Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 14.16 Cr.
The company currently has active open charges totaling ₹61.79 Cr. The company has closed loans amounting to ₹21.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Ocimum Labs Private Limited India is Ammanabolu Sushma as COMPANY SECRETARY. Jannu Bharath, Rani Aleti, Ramachandra Mandala, and One other member serve as directors at the Company.
- CIN/LLPIN
U24304TG2018PTC125461
- Company No.
125461
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jul 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ocimum Labs?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ammanabolu Sushma | Company Secretary | 01-Mar-2022 | Current |
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jannu Bharath | Director | 04-Apr-2019 | Current |
Rani Aleti | Director | 17-Sep-2018 | Current |
Ramachandra Mandala | Director | 04-Jul-2018 | Current |
Hari Mudduluru | Director | 04-Jul-2018 | Current |
Financial Performance of Ocimum Labs.
Ocimum Labs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 134.14% increase. The company also saw a substantial fall in profitability, with a 22.67% decrease in profit. The company's net worth Soared by an impressive increase of 23.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Ocimum Labs?
In 2023, Ocimum Labs had a promoter holding of 90.36% and a public holding of 9.64%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 19 Oct 2023 | ₹2.85 M | Open |
Others Creation Date: 30 Aug 2023 | ₹9.00 Cr | Open |
Others Creation Date: 21 Jul 2023 | ₹5.00 Cr | Open |
How Many Employees Work at Ocimum Labs?
Ocimum Labs has a workforce of 113 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ocimum Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ocimum Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.